Every filing, one decision per row.

Transactions

One row for every decision an insider filed. Open-market buying and selling only. Vesting, grants and the shares withheld to pay the tax on them are not decisions.

Company: IMVT Direction: Bought

Company

Date

Insider

Role

Action ?

Shares

Amount

Of holding

IMVT Immunovant, Inc.

12 Dec 2025

Roivant Sciences Ltd.

Director

Bought

16,666,666

$350.00M

17.2%

IMVT Immunovant, Inc.

13 Jan 2025

Roivant Sciences Ltd.

Director

Bought

16,845,010

$336.90M

21.1%

IMVT Immunovant, Inc.

2 Oct 2023

Roivant Sciences Ltd.

Director

Bought

1,526,316

$58.00M

1.9%

IMVT Immunovant, Inc.

6 Oct 2022

Roivant Sciences Ltd.

10% owner

Bought

416,667

$2.50M

0.6%

IMVT Immunovant, Inc.

30 Sep 2022

Director indirect

Bought

15,000

$84.00K

300%

IMVT Immunovant, Inc.

29 Sep 2022

Director

Bought

20,000

$116.20K

5.4%

IMVT Immunovant, Inc.

27 Aug 2021

Hughes Douglas J.

Director

Bought

18,247

$150.36K

45.4%

IMVT Immunovant, Inc.

20 Aug 2021

MIGAUSKY GEORGE V

Director

Bought

7,000

$53.55K

11.6%

IMVT Immunovant, Inc.

13 Aug 2021

Director indirect

Bought

5,000

$39.90K

12.4%

IMVT Immunovant, Inc.

10 Aug 2021

Fromkin Andrew J.

Director

Bought

5,500

$43.45K

13.7%

IMVT Immunovant, Inc.

11 Sep 2020

Butchko Julia G.

Chief Dev. & Tech. Officer

Bought

5,000

$190.85K

opened

IMVT Immunovant, Inc.

4 Sep 2020

Roivant Sciences Ltd.

10% owner

Bought

380,000

$12.54M

0.8%

IMVT Immunovant, Inc.

16 Apr 2020

Roivant Sciences Ltd.

10% owner

Bought

1,034,483

$15.00M

2.8%

IMVT Immunovant, Inc.

11 Dec 2019

Chief Executive Officer indirect

Bought

31,500

$344.02K

3.6%

IMVT Immunovant, Inc.

10 Dec 2019

Chief Executive Officer indirect

Bought

25,971

$269.52K

3.1%

IMVT Immunovant, Inc.

6 Dec 2019

Chief Executive Officer indirect

Bought 2×

450,000

$4.61M

114%

IMVT Immunovant, Inc.

5 Dec 2019

Chief Executive Officer indirect

Bought

20,000

$203.00K

5.3%

IMVT Immunovant, Inc.

4 Dec 2019

Chief Executive Officer indirect

Bought

20,000

$203.00K

5.6%

IMVT Immunovant, Inc.

3 Dec 2019

Chief Executive Officer indirect

Bought

20,000

$204.20K

6.0%

IMVT Immunovant, Inc.

2 Dec 2019

Chief Executive Officer indirect

Bought

20,000

$208.00K

6.3%

IMVT Immunovant, Inc.

29 Nov 2019

Chief Executive Officer indirect

Bought

26,918

$281.29K

9.3%

IMVT Immunovant, Inc.

27 Nov 2019

Chief Executive Officer indirect

Bought

4,000

$41.90K

1.4%

IMVT Immunovant, Inc.

26 Nov 2019

Chief Executive Officer indirect

Bought

4,000

$41.96K

1.4%

IMVT Immunovant, Inc.

25 Nov 2019

Chief Executive Officer indirect

Bought

4,000

$42.00K

1.4%

IMVT Immunovant, Inc.

22 Nov 2019

Chief Executive Officer indirect

Bought

2,000

$21.08K

0.7%

IMVT Immunovant, Inc.

21 Nov 2019

Chief Executive Officer indirect

Bought

15,194

$158.30K

5.9%

IMVT Immunovant, Inc.

20 Nov 2019

Chief Executive Officer indirect

Bought

29,805

$309.58K

13.0%

IMVT Immunovant, Inc.

19 Nov 2019

Chief Executive Officer indirect

Bought

29,805

$305.50K

15.0%

IMVT Immunovant, Inc.

18 Nov 2019

Chief Executive Officer indirect

Bought

29,805

$305.50K

17.6%

IMVT Immunovant, Inc.

15 Nov 2019

Chief Executive Officer indirect

Bought

13,000

$133.80K

8.3%

IMVT Immunovant, Inc.

14 Nov 2019

Chief Executive Officer indirect

Bought

13,000

$132.21K

9.1%

IMVT Immunovant, Inc.

13 Nov 2019

Chief Executive Officer indirect

Bought

13,000

$132.21K

10.0%

IMVT Immunovant, Inc.

12 Nov 2019

Chief Executive Officer indirect

Bought

100,000

$1.02M

328%

IMVT Immunovant, Inc.

11 Nov 2019

Chief Executive Officer indirect

Bought

13,000

$132.34K

74.3%

IMVT Immunovant, Inc.

7 Nov 2019

Chief Executive Officer indirect

Bought

17,500

$178.15K

opened

Showing 1–35 of 35.